ArticleMolecular and clinical oncology2021

A nomogram-based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancer.

Lingxiong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.